UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER IMAGE: BASED ON VIRTUAL AND IN VITRO ANTIVIRAL SCREENING THAT BEGAN IN THE EARLIER MONTHS OF THE COVID-19 PANDEMIC, THE RESEARCHERS LED AT UTHSC BY COLLEEN JONSSON, PHD, IDENTIFIED ZUCLOPENTHIXOL, NEBIVOLOL AND AMODIAQUINE AS A PROMISING THERAPEUTICS FOR TEH VIRUS IN ITS EARLY STAGES. Memphis, Tenn. (November 18, 2020)–Researchers at...
The World Health Organization is now advising doctors from using Gilead Sciences’ Remdesivir as a treatment for the global pandemic virus, COVID-19, saying that there is no sufficient evidence that shows its effects. The world is hanging on to the recommendations of the experts from WHO but the United States’ FDA already listed it as...
BOSTON UNIVERSITY Scientists are still solving the many puzzling aspects of how the novel coronavirus attacks the lungs and other parts of the body. One of the biggest and most life-threatening mysteries is how the virus causes “silent hypoxia,” a condition when oxygen levels in the body are abnormally low, which can irreparably damage vital...
by American Society for Microbiology Credit: CC0 Public Domain The measles-mumps-rubella (MMR) vaccine has been theorized to provide protection against COVID-19. In a new study published in mBio, an open-access journal of the American Society for Microbiology, researchers provide further proof of this by showing that mumps IgG titers, or levels of IgG antibody, are inversely correlated with severity...
Preliminary results of patient tissue analysis show that the virus infects adipocytes and alters the quantity of signaling molecules released by these cells into the bloodstream FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO IMAGE: ISOLATED EXOSOMES FROM PATIENT SERUM SAMPLES. PRELIMINARY RESULTS SHOW THAT THE VIRUS INFECTS ADIPOCYTES AND ALTERS THE QUANTITY...
by UT Southwestern Medical Center Emily Adhikari, M.D. Pregnant women who test positive for COVID-19 and their newborn babies have a low risk of developing severe symptoms, according to a new study from UT Southwestern. The study, published today in JAMA Network Open, shows that 95 percent of women who tested positive for COVID-19 during pregnancy had no adverse...
by Queensland University of Technology Dr. Lisa Philp and Professor Colleen Nelson, from the QUT Faculty of Health’s School of Biomedical Science, are developing drugs to fight advanced prostate cancer that could also prevent and or treat acute respiratory distress syndrome (ARDS). They and their research team, based at the Translational Research Institute, realized their research...
by Washington University School of Medicine Emergency medicine physician Philip Mudd, MD, PhD, carries an icebox containing COVID-19 samples. Mudd led a study at Washington University School of Medicine in St. Louis that showed that, contrary to expectation, most people with severe COVID-19 do not suffer from unbridled inflammation. The findings suggest that anti-inflammatory therapies may...
COVID-19 can do some pretty scary things to the human heart. It can trigger blood clots in severe cases and cause inflammation and scarring. New research now shows that even young people with COVID-19 who are asymptomatic are at risk for developing potentially dangerous inflammation around the heart. I am an imaging cardiologist who is developing diagnostic techniques to assess...
by University of Tokyo Credit: Pixabay/CC0 Public Domain Why did Japan largely contain COVID-19 despite famously jam-packed Tokyo and despite the country’s proximity to China? With no penalties and only requests for cooperation, Japan’s state of emergency somehow averted the large-scale outbreaks seen elsewhere. At least one viable answer has now emerged. A new comparative analysis...
